A S Chemopharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 23-10-2024
- Paid Up Capital ₹ 1.15 M
as on 23-10-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.12 Cr
as on 23-10-2024
- Revenue -13.01%
(FY 2023)
- Profit 539.79%
(FY 2023)
- Ebitda 35.94%
(FY 2023)
- Net Worth 3.81%
(FY 2023)
- Total Assets -37.83%
(FY 2023)
About A S Chemopharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.15 M.
The company currently has active open charges totaling ₹2.12 Cr.
Sunil Sharma, Anju Sharma, Meenu Sharma, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230MH2006PTC158534
- Company No.
158534
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does A S Chemopharma Private Limited offer?
A S Chemopharma Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Organic Chemicals, Chemical Reagents & Catalysts, Organic Compounds, Flavours & Aromatics, Food Additive.
Who are the key members and board of directors at A S Chemopharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Trilokinath Sharma  | Managing Director | 02-Jan-2006 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Sharma | Director | 01-Apr-2007 | Current |
| Anju Sharma | Director | 03-Feb-2011 | Current |
| Meenu Sharma | Director | 03-Feb-2011 | Current |
| Kunal Sharma | Additional Director | 19-Nov-2020 | Current |
| Ravi Sharma | Director | 01-Apr-2007 | Current |
Financial Performance of A S Chemopharma.
A S Chemopharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.01% decrease. The company also saw a substantial improvement in profitability, with a 539.79% increase in profit. The company's net worth moved up by a moderate rise of 3.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A S Chemopharma?
In 2023, A S Chemopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shiel Ice And Chemicals Private LimitedActive 34 years 6 monthsSunil Sharma and Ravi Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 27 Mar 2018 | ₹1.20 M | Open |
Canara Bank Creation Date: 23 Mar 2016 | ₹1.00 M | Open |
Canara Bank Creation Date: 03 Dec 2011 | ₹9.50 M | Open |
How Many Employees Work at A S Chemopharma?
A S Chemopharma has a workforce of 7 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A S Chemopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A S Chemopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
